Eczema Trial, Recruiting NCT07056569 Sponsor: Biokosmes Srl Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT07056569
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People older than 6 months and younger than 65 years of age
  • People who have been diagnosed with atopic dermatitis (a type of eczema) or contact dermatitis (a skin reaction caused by touching something)
  • People whose skin condition is considered mild to moderate, based on a specific scoring system used by doctors (a score called EASI of 16 or below)
  • People whose skin condition falls within a certain severity range as assessed by a doctor using a standard rating scale (a score called IGA of 1 to 3)
  • People who are generally in good health with no serious illnesses affecting the whole body

Who may not be able to join:

  • People who have a known allergy or sensitivity to any ingredient in the study cream (called 047_TD Dermatitis cream)
  • People who have another skin condition in the area being studied that could affect how doctors evaluate the results, in the opinion of the investigating doctor
  • People who have used other treatments for their skin condition — such as UV light therapy, probiotics, or homeopathy — within the 30 days before the study starts, or who plan to use them during the study
  • People who use any other moisturising creams or standard treatments for their skin condition on the affected areas during the study (regular hygiene products used in the nappy area are an exception)
  • People who are currently receiving or have a history of receiving treatments that suppress the immune system, chemotherapy, or radiation therapy
  • People who currently misuse drugs or substances
  • People who are not willing to follow all the procedures and requirements of the study, or, for participants under 18 years old, whose parents or guardians are not willing to agree on their behalf
  • People who are unable to provide written consent to participate, or, for participants under 18 years old, whose parents or guardians are unable to provide written consent on their behalf

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41 79 844 2600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Biokosmes Srl
Registry
ClinicalTrials.gov
Start date
5 June 2025
Est. completion
1 August 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Performance measured by reduction of disease severity and symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov